Combining plasma glucose, insulin and C-peptide, insulinoma patients have higher fasting insulin and fasting C-peptide than the control group, indicating that insulinoma patients are more likely to have fasting hypoglycemia symptoms. The gene discussed is INS; the disease is pancreatic insulinoma.